Apogee Therapeutics, Inc. Number of Reportable Segments
Apogee Therapeutics, Inc. (APGE) reported Number of Reportable Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-08-10
- Apogee Therapeutics, Inc. number of reportable segments for the quarter ending 2024-03-31 was 1.00 segment.
- Apogee Therapeutics, Inc. number of reportable segments for fiscal 2023 was 1.00 segment.
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 1.00 segment 10-K · filed 2024-03-05 |
Segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-10 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-11 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-02 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-10 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-11 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-12 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-03-03 | |||
| 2024-09-30 | 1.00 Segment 10-Q · filed 2024-11-12 | |||
| 2024-06-30 | 1.00 Segment 10-Q · filed 2024-08-12 |